Blue Owl Capital Holdings »

Chime Finl shares owned by Blue Owl Capital Holdings

Quarter-by-quarter ownership of Chime Finl (CHYM) shares owned by Blue Owl Capital Holdings from 13F filings

Historical chart of Blue Owl Capital Holdings investment in Chime Finl

Tip: Access up to 7 years of quarterly data

All positions including Chime Finl held by Blue Owl Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Chime Finl by Blue Owl Capital Holdings

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.0M 40k 25.17

More positions owned by Blue Owl Capital Holdings

Engene Holdings (ENGN)
Nuveen Churchill Direct Lend Com Shs (NCDL)
Owl Rock Capital Corporation (OBDC)
Larimar Therapeutics (LRMR)
Cullinan Oncology (CGEM)
Compass Therapeutics (CMPX)
Holley (HLLY)
Context Therapeutics (CNTX)
Conduent Incorporate (CNDT)
Repare Therapeutics Ord
Civeo Corp Cda Com New (CVEO)
Sagimet Biosciences Com Ser A (SGMT)
Eyepoint Com New (EYPT)
Procore Technologies (PCOR)
Dell Technologies CL C (DELL)

View all positions for Blue Owl Capital Holdings

Top funds holding Chime Finl

Galileo
Crosslink Capital
General Atlantic
Tiger Global Management
ICONIQ Capital
Coatue Management
Forerunner Ventures Management
Dragoneer Investment
Capital Research Global Investors
Ashton Thomas Private Wealth
Softbank Group Corp
Orland Properties
Point72 Asset Management
Scge Management
Greenhouse Funds L

View all funds holding Chime Finl